Statistics
Publications
32
Citations
3.1K
H-Index
21
Active since
1993
Philipp K. Haber is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and surgery.
Publications per year
1993–2024
32
32
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text
Life Sciences, Immunology, Oncology +17
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Carla Montironi, Florian Castet, Philipp K. Haber et al. · Gut · 2022 · 236 citations · Full text
Medicine, Immunology, Oncology +16
CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 228 citations · Full text
Medicine, Immunology, Oncology +17
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
Philipp K. Haber, Florian Castet, Miguel Torres‐Martín et al. · Gastroenterology · 2022 · 146 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–5 of 32